This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Study of Psilocybin for Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03866174
Recruitment Status : Completed
First Posted : March 7, 2019
Last Update Posted : June 5, 2023
The Emmes Company, LLC
Information provided by (Responsible Party):
Usona Institute

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 28, 2022
Actual Study Completion Date : June 28, 2022
Certification/Extension First Submitted : May 18, 2023

Publications automatically indexed to this study by Identifier (NCT Number):